CEBPZ and acute myeloid leukemia: Our study not only consistently reveals independent prognostic value of mRNA expression of IL2RA in AML, particularly in CBF and intermediate-risk AML, but also serves as a proof-of-concept study for future research endeavors to investigate prognostic roles of mRNA expression of other CD biomarkers.